Tβ4–17 Boosts Ovarian Cancer Chemo-Sensitivity via NF-κB
In a groundbreaking advance that could revolutionize the treatment landscape for ovarian cancer, researchers have unveiled compelling evidence that the Tβ4–17 peptide significantly enhances the...
















